Amdocs Limited
Amdocs Limited is a global provider of software solutions and associated services, operating through various subsidiaries worldwide. The company was established in 1988 and maintains its corporate headquarters in Saint Louis, Missouri. Amdocs is actively involved in the full lifecycle of its cloud-based portfolio,…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
1D
-1.0%
1W
+2.1%
1M
-2.2%
6M
-11.2%
YTD
-25.4%
1Y
-27.2%
2Y
-33.0%
5Y
-25.5%
10Y
+0.8%
Next earnings date
10/11/2026 (in 24 days)
Volatility around earnings
~49% stronger price swings than usual
PRICE TARGET LOW
US$71.00
CONSENSUS
US$71.00
MEDIAN
US$71.00
PRICE TARGET HIGH
US$71.00
0
STRONG BUY
7
BUY
4
HOLD
0
SELL
0
STRONG SELL
11
TOTAL · Buy
As of: 14/05/2026
P/E
14.23
P/B
1.93
EV/EBITDA
8.67
RETURN ON EQUITY
1.9%
NET MARGIN
5.3%
DEBT/EQUITY
0.33
DIVIDEND YIELD
3.7%
AS OF
30/06/2026
FREE FLOAT
95.8%
FLOAT SHARES
103,099,371
AVG. DAILY VOLUME (30D)
960,421
Smith Matthew E.
Hortig Shimie
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.0%
Forums (Reddit)
Amdocs Limited is a company in the Technology sector, Software - Infrastructure industry, headquartered in United States.
The CEO is Shimie Hortig, the company employs around 26,969 people.
The IPO was on 19/06/1998; the stock trades on NASDAQ under the ticker DOX.
11 analysts rate the stock, the consensus is Buy (as of 14/05/2026).
The average price target is US$71.00, ranging from US$71.00 to US$71.00, with a median of US$71.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 10/11/2026.
Around past earnings, price swings were roughly 49% stronger than usual.
Yes. The last dividend was US$0.57 per share, ex-date 30/09/2026, paid on 30/10/2026.
The dividend yield is 3.7% (as of 30/06/2026).
Comparable stocks include Microsoft, Palantir Technologies, Oracle, Palo Alto Networks, CrowdStrike Holdings, Fortinet, Cloudflare and Synopsys.
Clicking "Analyze stock" lets five strategies assess Amdocs against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.